[go: up one dir, main page]

MX2011008400A - Lactobacillus rhamnosus cncm i-4096 y el control del peso. - Google Patents

Lactobacillus rhamnosus cncm i-4096 y el control del peso.

Info

Publication number
MX2011008400A
MX2011008400A MX2011008400A MX2011008400A MX2011008400A MX 2011008400 A MX2011008400 A MX 2011008400A MX 2011008400 A MX2011008400 A MX 2011008400A MX 2011008400 A MX2011008400 A MX 2011008400A MX 2011008400 A MX2011008400 A MX 2011008400A
Authority
MX
Mexico
Prior art keywords
lactobacillus rhamnosus
weight control
rhamnosus cncm
present
obesity
Prior art date
Application number
MX2011008400A
Other languages
English (en)
Inventor
Catherine Mace
Christian Darimont-Nicolau
Fabrizio Arigoni
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2011008400A publication Critical patent/MX2011008400A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14—Yeasts or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Nutrition Science (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

En general, la presente invención se refiere al campo de la obesidad. En particular, la presente invención se refiere al uso de probióticos para apoyar el manejo del peso y para tratar o prevenir la obesidad. Una modalidad de la presente invención se refiere al uso del Lactobacillus rhamnosus CNCM I-4096 para la preparación de una composición para apoyar el manejo del peso, promover la pérdida de peso y/o para tratar la obesidad.
MX2011008400A 2009-02-10 2010-02-04 Lactobacillus rhamnosus cncm i-4096 y el control del peso. MX2011008400A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09152435A EP2216035A1 (en) 2009-02-10 2009-02-10 Lactobacillus rhamnosus CNCM I-4096 and weight control
PCT/EP2010/051364 WO2010091993A1 (en) 2009-02-10 2010-02-04 Lactobacillus rhamnosus cncm i-4096 and weight control

Publications (1)

Publication Number Publication Date
MX2011008400A true MX2011008400A (es) 2011-09-01

Family

ID=40762310

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011008400A MX2011008400A (es) 2009-02-10 2010-02-04 Lactobacillus rhamnosus cncm i-4096 y el control del peso.

Country Status (8)

Country Link
US (1) US8318150B2 (es)
EP (2) EP2216035A1 (es)
CN (1) CN102316881B (es)
AU (1) AU2010213010B2 (es)
BR (1) BRPI1008327A2 (es)
CL (1) CL2011001937A1 (es)
MX (1) MX2011008400A (es)
WO (1) WO2010091993A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012131099A1 (en) * 2011-03-31 2012-10-04 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of blood or tissue bacteriome for prediction, diagnosis and prevention of metabolic diseases and their cardiovascular complications
CN104955467A (zh) * 2012-11-12 2015-09-30 热尔韦·达诺尼公司 鼠李糖乳杆菌菌株用于降低身体脂肪积累
MX2015005898A (es) * 2012-11-12 2016-02-05 Gervais Danone Sa Uso de una cepa de lactobacillus rhamnosus para reducir la ganancia de peso o la resistencia a la insulina, o ambas cosas al mismo tiempo.
EP2979088B1 (en) * 2013-03-28 2018-05-16 Nestec S.A. Alpha-keto-isovalerate as a biomarker of prebiotic efficacy for weight gain prevention
FR3004621B1 (fr) * 2013-04-19 2015-05-15 Gervais Danone Sa Souche de lactobacillus rhamnosus regulatrice du metabolisme lipidique
WO2015159125A1 (en) * 2014-04-15 2015-10-22 Compagnie Gervais Danone Use of lactobacillus rhamnosus for promoting recovery of the intestinal microbiota diversity after antibiotic dysbiosis
CN103947962B (zh) * 2014-05-09 2015-10-28 上海盛世中侬农业科技发展有限公司 一种减肥食品
KR102125548B1 (ko) 2015-02-10 2020-06-24 주식회사 지니스 비만 억제능을 갖는 균주 및 이를 함유하는 약학 조성물
CN107949633B (zh) * 2015-08-12 2021-04-30 Cj第一制糖株式会社 鼠李糖乳杆菌、动物饲料及其组合物及无活性细胞生产法
CN109757730B (zh) * 2019-01-31 2021-06-04 山东环亿生物科技有限公司 一种具有降血脂、血压以及血糖的组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
EP1372412A2 (en) * 2001-03-09 2004-01-02 Societe Des Produits Nestle S.A. Composition improving age-related physiological deficits and increasing longevity
US20040001898A1 (en) * 2002-06-26 2004-01-01 Armand Malnoe Compositions and methods for detoxification and cancer prevention
US7001756B1 (en) 2004-02-19 2006-02-21 Genmont Biotech Inc. Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity
CN100396770C (zh) 2004-03-19 2008-06-25 景岳生物科技股份有限公司 新的微生物鼠李糖乳杆菌gm-020及其治疗肥胖的用途
KR100686557B1 (ko) 2004-08-16 2007-02-23 씨제이 주식회사 체지방 저하 기능성 락토바실러스 람노서스와 이를 함유한 식품
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity

Also Published As

Publication number Publication date
WO2010091993A1 (en) 2010-08-19
AU2010213010A1 (en) 2011-08-25
AU2010213010B2 (en) 2014-10-30
EP2396012A1 (en) 2011-12-21
EP2216035A1 (en) 2010-08-11
US8318150B2 (en) 2012-11-27
BRPI1008327A2 (pt) 2016-02-23
CN102316881B (zh) 2013-08-07
US20110293569A1 (en) 2011-12-01
CN102316881A (zh) 2012-01-11
CL2011001937A1 (es) 2012-01-20

Similar Documents

Publication Publication Date Title
MX2011008398A (es) Lactobacillus helveticus cncm i-4095 y el control del peso.
MX2011008399A (es) Lactobacillus rhamnosus ncc4007, una mezcla probiotica y el control del peso.
MX2011008400A (es) Lactobacillus rhamnosus cncm i-4096 y el control del peso.
PH12012501257A1 (en) Capsule for the preparation of a beverage comprising an identification code
MY155516A (en) Lactobacillus rhamnosus and weight control
IN2012DN02463A (es)
ATE537707T1 (de) Lactobacillus paracasei und gewichtskontrolle
GB2460781B (en) Probiotic bifidobacterium strains
GB2465051B (en) Probiotic bifidobacterium strains
PL2626076T3 (pl) Zastosowania terapeutyczne Lactobacillus salivarius LS01 DSM 22775
PL2498789T3 (pl) Probiotyczny szczep bifidobacterium
PH12012500847A1 (en) Novel lactobacillus plantarum and composition comprising the same
PL2485743T3 (pl) Szczepy Lactobacillus plantarum jako czynniki hipocholesterolemiczne
PT2332520T (pt) Lactobacillus paracasei para tratar os pontos de senescência e/ou melasma
PL2268792T3 (pl) Szczep lactobacillus rhamnosus
PL2568815T3 (pl) Fermentacja synergistyczna lactobacillus rhamnosus i lactobacillus paracasei podgatunek paracasei
MX2011005527A (es) Uso de la bacteria de acido lactico para tratar o prevenir el eczema.
MX2015005898A (es) Uso de una cepa de lactobacillus rhamnosus para reducir la ganancia de peso o la resistencia a la insulina, o ambas cosas al mismo tiempo.
PL2276498T3 (pl) Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii
AP2012006139A0 (en) Composition comprising strains of lactobacillus fermentum.
MX2012013835A (es) Cepas probioticas para aumentar la resistencia transepitelial.
MY158310A (en) Prevention and treatment of allergic diarrhoea
MX2015005897A (es) Cepa de lactobacillus rhamnosus para reducir la acumulacion de grasa corporal.
MX2014001572A (es) Nueva cepa de l.bulgaricus con capacidad de inhibir la adhesion de cepas de h. pylori a celulas epiteliales.
PL2593539T3 (pl) Zastosowanie manganu do wzmacniania wzrostu bakterii L.Casei w mieszanych kulturach

Legal Events

Date Code Title Description
FG Grant or registration